| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.00M | 42.00M | 6.00M | 150.00M | 159.00M | 282.00M |
| Gross Profit | 52.00M | 27.00M | 6.00M | 74.00M | -197.00M | 190.00M |
| EBITDA | -67.00M | -441.00M | -273.00M | 32.00M | -264.00M | -350.00M |
| Net Income | -225.00M | -447.00M | -491.00M | -195.00M | -445.00M | -578.00M |
Balance Sheet | ||||||
| Total Assets | 2.13B | 2.17B | 2.61B | 3.38B | 4.70B | 5.75B |
| Cash, Cash Equivalents and Short-Term Investments | 1.06B | 1.01B | 107.00M | 2.23B | 2.69B | 2.71B |
| Total Debt | 2.81B | 2.74B | 3.16B | 3.10B | 3.21B | 3.56B |
| Total Liabilities | 4.30B | 4.24B | 4.25B | 4.25B | 5.00B | 5.60B |
| Stockholders Equity | -2.18B | -2.09B | -1.66B | -882.00M | -313.00M | 136.00M |
Cash Flow | ||||||
| Free Cash Flow | -178.00M | -176.00M | -195.00M | -418.00M | 510.00M | -390.00M |
| Operating Cash Flow | -178.00M | -176.00M | -195.00M | -418.00M | 511.00M | -390.00M |
| Investing Cash Flow | 172.00M | 287.00M | 767.00M | 623.00M | -61.00M | 1.74B |
| Financing Cash Flow | -25.00M | -132.00M | -542.00M | -285.00M | -457.00M | -1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $4.63B | 8.60 | 13.07% | 3.00% | 0.24% | 3.14% | |
| ― | $503.55M | 15.26 | 12.55% | 5.98% | 15.28% | 26.05% | |
| ― | $3.92B | 8.97 | 8.38% | 1.62% | 5.89% | -27.45% | |
| ― | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
| ― | $1.88B | 170.69 | 3.33% | ― | 13.11% | ― | |
| ― | $392.09M | ― | -4.09% | ― | -17.06% | -118.90% | |
| ― | $347.87M | -1.47 | ― | ― | ― | 66.83% |
On August 14, 2025, National sold Custodial Receipts (CRs) representing bankruptcy claims in a transaction involving approximately $374 million face amount of CRs. This sale, which follows similar transactions in October 2021 and January 2022, reduces potential volatility and ongoing risk for National’s remaining PREPA exposure, as the Title III case remains uncertain.
The most recent analyst rating on (MBI) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on MBIA stock, see the MBI Stock Forecast page.
The recent earnings call for MBIA Inc. reflected a cautiously optimistic outlook, marked by a notable reduction in net losses and a positive shift in statutory income figures. Despite these improvements, the company continues to face challenges, particularly with a decrease in book value and unresolved issues related to PREPA exposure, which present ongoing risks.
MBIA Inc. operates in the financial guarantee insurance industry, primarily providing credit protection through its U.S. public finance, corporate, and international and structured finance insurance segments. The company is known for managing complex financial risks and offering insurance solutions to various sectors, including municipal bonds and structured finance.
MBIA announced that it will release its Quarterly Operating Supplement and Quarterly Statements for the second quarter of 2025 on August 6, 2025. These documents, along with updates to the company’s insured portfolios and investor inquiries, will be made available on MBIA’s website, providing stakeholders with detailed insights into the company’s financial performance and insurance operations.
The most recent analyst rating on (MBI) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on MBIA stock, see the MBI Stock Forecast page.